{"count":21,"summary":"Found 21 ATM offerings in the past 72 hours. Top filers: Indaptus Therapeutics, Inc., FARADAY FUTURE INTELLIGENT ELECTRIC INC., VEEA INC..","filings":[{"accession_number":"0001493152-26-030346","company_name":"Indaptus Therapeutics, Inc.","filed_at":"2026-06-26T17:21:32-04:00","cik":"1857044","form_type":"S-3","shelf_size_usd":20000000,"shelf_size_million_usd":20.0,"is_atm":true,"sales_agents":["H.C. Wainwright"],"use_of_proceeds_excerpt":"9 DIVIDEND POLICY 10 SELLING STOCKHOLDERS 10 PLAN OF DISTRIBUTION 12 DESCRIPTION OF SECURITIES 14 LEGAL MATTERS 20 EXPERTS 21 WHERE YOU CAN FIND MORE INFORMATION 21 INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE 21 i ABOUT THIS PROSPECTUS This prosp"},{"accession_number":"0001213900-26-072709","company_name":"FARADAY FUTURE INTELLIGENT ELECTRIC INC.","filed_at":"2026-06-26T17:14:07-04:00","cik":"1805521","form_type":"S-3","shelf_size_usd":300000000,"shelf_size_million_usd":300.0,"is_atm":true,"sales_agents":["A.G.P./Alliance Global Partners","Maxim Group"],"use_of_proceeds_excerpt":"Except as otherwise set forth in any accompanying prospectus supplement, we expect to use the net proceeds from the sale of securities offered by this prospectus in connection with the primary offering for general corporate purposes, including the fi"},{"accession_number":"0001213900-26-072701","company_name":"VEEA INC.","filed_at":"2026-06-26T17:09:26-04:00","cik":"1840317","form_type":"S-3","shelf_size_usd":75000000,"shelf_size_million_usd":75.0,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"9 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS 10 PLAN OF DISTRIBUTION 11 THE SECURITIES WE MAY OFFER 14 DESCRIPTION OF SHARES OF OUR SECURITIES 15 DESCRIPTION OF SECURITIES WE MAY OFFER 21 FORMS OF SECURITIES 28 LEGAL MATTERS 29 EXPERTS 29 WHERE Y"},{"accession_number":"0001493152-26-030339","company_name":"U.S. GoldMining Inc.","filed_at":"2026-06-26T17:09:09-04:00","cik":"1947244","form_type":"424B5","shelf_size_usd":5906045,"shelf_size_million_usd":5.906045,"is_atm":true,"sales_agents":["H.C. Wainwright","Stifel"],"use_of_proceeds_excerpt":""},{"accession_number":"0001104659-26-078297","company_name":"HERTZ GLOBAL HOLDINGS, INC","filed_at":"2026-06-26T16:30:44-04:00","cik":"1657853","form_type":"424B5","shelf_size_usd":400000000,"shelf_size_million_usd":400.0,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"​ ​ ​ ​ 10 ​ ​ Description of Share Lending Agreement ​ ​ ​ ​ 11 ​ ​ Description of Capital Stock ​ ​ ​ ​ 12 ​ ​ Material U.S. Federal Income and Estate Tax Consequences for Non-U.S. Holders of Our Common Stock ​ ​ ​ ​ 16 ​ ​ Dividend Policy ​ ​ ​ ​ "},{"accession_number":"0001079973-26-000879","company_name":"Ascent Solar Technologies, Inc.","filed_at":"2026-06-26T16:30:13-04:00","cik":"1350102","form_type":"424B5","shelf_size_usd":100000000,"shelf_size_million_usd":100.0,"is_atm":true,"sales_agents":["H.C. Wainwright"],"use_of_proceeds_excerpt":"S-9 DILUTION S-9 PLAN OF DISTRIBUTION S-11 LEGAL MATTERS S-13 EXPERTS S-13 WHERE YOU CAN FIND MORE INFORMATION S-13 INCORPORATION OF CERTAIN INFORMATION BY REFERENCE S-14 Prospectus Page ABOUT THIS PROSPECTUS ii CAUTIONARY STATEMENT REGARDING FORWARD"},{"accession_number":"0001193125-26-285537","company_name":"SURF AIR MOBILITY INC.","filed_at":"2026-06-26T16:23:01-04:00","cik":"1936224","form_type":"424B5","shelf_size_usd":null,"shelf_size_million_usd":null,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"S-8 PLAN OF DISTRIBUTION S-9 LEGAL MATTERS S-10 EXPERTS S-10 WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION BY REFERENCE S-11 Prospectus Page ABOUT THIS PROSPECTUS 15 WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION BY REFERENCE 16 CAUTIONARY S"},{"accession_number":"0001104659-26-078241","company_name":"SOLIGENIX, INC.","filed_at":"2026-06-26T16:05:18-04:00","cik":"812796","form_type":"424B5","shelf_size_usd":6406000,"shelf_size_million_usd":6.406,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":""},{"accession_number":"0001493152-26-030257","company_name":"Youxin Technology Ltd","filed_at":"2026-06-26T14:11:29-04:00","cik":"1964946","form_type":"424B5","shelf_size_usd":100000000,"shelf_size_million_usd":100.0,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"S-10 Dividend Policy S-10 Dilution S-11 Plan of Distribution S-12 Legal Matters S-14 Experts S-14 Where You Can Find More Information S-14 Incorporation of Certain Information by Reference S-15 Prospectus Page ABOUT THIS PROSPECTUS ii SPECIAL NOTE RE"},{"accession_number":"0001213900-26-072404","company_name":"Eco Wave Power Global AB","filed_at":"2026-06-26T09:53:26-04:00","cik":"1846715","form_type":"424B5","shelf_size_usd":null,"shelf_size_million_usd":null,"is_atm":true,"sales_agents":["Maxim Group"],"use_of_proceeds_excerpt":"S-9 Offer and Listing Details S-10 Dividend Policy S-11 Capitalization S-12 Dilution S-13 Description of Securities we are Offering S-14 Plan of Distribution S-16 Legal Matters S-18 Experts S-18 Where You Can Find More Information S-18 Incorporation "},{"accession_number":"0001104659-26-078043","company_name":"Kimbell Royalty Partners, LP","filed_at":"2026-06-26T09:16:28-04:00","cik":"1657788","form_type":"S-3","shelf_size_usd":null,"shelf_size_million_usd":null,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"​ ​ ​ ​ 6 ​ ​ ​ DESCRIPTION OF OUR COMMON UNITS AND CLASS B UNITS ​ ​ ​ ​ 7 ​ ​ ​ DESCRIPTION OF THE PREFERRED UNITS ​ ​ ​ ​ 10 ​ ​ ​ CASH DISTRIBUTION POLICY AND RESTRICTIONS ON DISTRIBUTIONS ​ ​ ​ ​ 12 ​ ​ ​ HOW WE PAY DISTRIBUTIONS ​ ​ ​ ​ 15 ​ ​ "},{"accession_number":"0001104659-26-077891","company_name":"ProQR Therapeutics N.V.","filed_at":"2026-06-25T20:12:17-04:00","cik":"1612940","form_type":"424B5","shelf_size_usd":300000000,"shelf_size_million_usd":300.0,"is_atm":true,"sales_agents":["Cantor Fitzgerald"],"use_of_proceeds_excerpt":"​ ​ ​ ​ S-15 ​ ​ ​ DIVIDEND POLICY ​ ​ ​ ​ S-16 ​ ​ ​ CAPITALIZATION ​ ​ ​ ​ S-17 ​ ​ ​ DILUTION ​ ​ ​ ​ S-18 ​ ​ ​ TAXATION ​ ​ ​ ​ S-20 ​ ​ ​ UNDERWRITING ​ ​ ​ ​ S-31 ​ ​ ​ EXPENSES RELATED TO THE OFFERING ​ ​ ​ ​ S-40 ​ ​ ​ LEGAL MATTERS ​ ​ ​ ​ "},{"accession_number":"0001493152-26-030170","company_name":"Aether Holdings, Inc.","filed_at":"2026-06-25T17:10:33-04:00","cik":"2026353","form_type":"424B5","shelf_size_usd":100000000,"shelf_size_million_usd":100.0,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"S-6 dilution S-7 DIVIDEND POLICY S-8 PLAN OF DISTRIBUTION S-9 LEGAL MATTERS S-10 CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE S-10 EXPERTS S-10 WHERE YOU CAN FIND MORE INFORMATION S-10 INCORPORATION BY REFERENC"},{"accession_number":"0001193125-26-282846","company_name":"Taysha Gene Therapies, Inc.","filed_at":"2026-06-25T16:24:12-04:00","cik":"1806310","form_type":"424B5","shelf_size_usd":null,"shelf_size_million_usd":null,"is_atm":true,"sales_agents":["Cantor Fitzgerald","Jefferies","Piper Sandler","Leerink","Goldman Sachs"],"use_of_proceeds_excerpt":"S-20 DILUTION S-21 DESCRIPTION OF CAPITAL STOCK S-23 DESCRIPTION OF THE PRE-FUNDED WARRANTS S-31 MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES S-34 UNDERWRITING S-40 LEGAL MATTERS S-49 EXPERTS S-49 WHERE YOU CAN FIND MORE INFORMATION S-50 INCORPORATI"},{"accession_number":"0001193125-26-282783","company_name":"Q32 Bio Inc.","filed_at":"2026-06-25T16:11:56-04:00","cik":"1661998","form_type":"S-3","shelf_size_usd":300000000,"shelf_size_million_usd":300.0,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"9 DESCRIPTION OF CAPITAL STOCK 10 DESCRIPTION OF DEBT SECURITIES 15 DESCRIPTION OF WARRANTS 17 DESCRIPTION OF UNITS 18 TAXATION 19 PLAN OF DISTRIBUTION 20 LEGAL MATTERS 24 EXPERTS 24 WHERE YOU CAN FIND MORE INFORMATION 24 INCORPORATION BY REFERENCE 2"},{"accession_number":"0001213900-26-071836","company_name":"TOYO Co., Ltd","filed_at":"2026-06-25T10:28:40-04:00","cik":"1985273","form_type":"424B5","shelf_size_usd":200000000,"shelf_size_million_usd":200.0,"is_atm":true,"sales_agents":["H.C. Wainwright","Roth Capital"],"use_of_proceeds_excerpt":"S-9 Description of Securities Offered S-10 Dilution S-12 Plan of Distribution S-13 Legal Matters S-15 Experts S-15 Information Incorporated by Reference S-15 Where You Can Find More Information S-16 Prospectus Page About this Prospectus ii Commonly U"},{"accession_number":"0001193125-26-281815","company_name":"Nuvation Bio Inc.","filed_at":"2026-06-25T07:08:03-04:00","cik":"1811063","form_type":"424B5","shelf_size_usd":600000000,"shelf_size_million_usd":600.0,"is_atm":true,"sales_agents":["Cantor Fitzgerald","Jefferies","Citigroup Global Markets"],"use_of_proceeds_excerpt":"S-22 CAPITALIZATION S-23 DESCRIPTION OF OTHER INDEBTEDNESS AND CERTAIN REVENUE PARTICIPATION RIGHTS… S-25 DESCRIPTION OF NOTES S-27 DESCRIPTION OF CAPPED CALL TRANSACTIONS S-66 MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS S-67 UNDERWRITING S-77 LE"},{"accession_number":"0001193125-26-281131","company_name":"Absci Corp","filed_at":"2026-06-24T16:30:10-04:00","cik":"1672688","form_type":"424B5","shelf_size_usd":400000000,"shelf_size_million_usd":400.0,"is_atm":true,"sales_agents":["Jefferies","Cowen","Guggenheim"],"use_of_proceeds_excerpt":"S-11 DILUTION S-12 MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS S-14 UNDERWRITERS S-18 LEGAL MATTERS S-22 EXPERTS S-22 WHERE YOU CAN FIND MORE INFORMATION S-22 INCORPORATION OF CERTAIN INFORMATION BY REFERENCE S-23 Prospectus ABO"},{"accession_number":"0001213900-26-071382","company_name":"GD Culture Group Ltd","filed_at":"2026-06-24T11:42:16-04:00","cik":"1641398","form_type":"424B5","shelf_size_usd":500000000,"shelf_size_million_usd":500.0,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"S-19 PLAN OF DISTRIBUTION S-20 LEGAL MATTERS S-22 EXPERTS S-22 INTERESTS OF EXPERTS AND COUNSEL S-22 INCORPORATION OF DOCUMENTS BY REFERENCE S-23 WHERE YOU CAN FIND ADDITIONALINFORMATION S-24 PROSPECTUS Page ABOUT THIS PROSPECTUS ii COMMONLY USED DEF"},{"accession_number":"0001563411-26-000183","company_name":"CONSTELLIUM SE","filed_at":"2026-06-24T11:34:10-04:00","cik":"1563411","form_type":"S-3ASR","shelf_size_usd":null,"shelf_size_million_usd":null,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"Unless we state differently in the applicable prospectus supplement, we expect to use the net proceeds we receive from the sale of the ordinary shares offered by us pursuant to this prospectus and any applicable prospectus supplement for general corp"},{"accession_number":"0001104659-26-077051","company_name":"HERTZ GLOBAL HOLDINGS, INC","filed_at":"2026-06-24T07:17:48-04:00","cik":"1657853","form_type":"S-3ASR","shelf_size_usd":345000000,"shelf_size_million_usd":345.0,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"​ ​ ​ ​ 10 ​ ​ Description of Share Lending Agreement ​ ​ ​ ​ 11 ​ ​ Description of Capital Stock ​ ​ ​ ​ 12 ​ ​ Material U.S. Federal Income and Estate Tax Consequences for Non-U.S. Holders of Our Common Stock ​ ​ ​ ​ 16 ​ ​ Dividend Policy ​ ​ ​ ​ "}],"note":"Showing past 72h. Free 3-day Pro trial (no card): https://filingfirehose.com/trial"}